NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Walmart Inc. (“Walmart” or the “Company”) (NYSE: WMT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Zillow Group, Inc. (“Zillow” or the “Company”) (NASDAQ: Z; ZG) and certain of its officers. The class action, Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Citrix Systems, Inc. (“Citrix” or the “Company”) (CTXS) – Get Citrix Systems, Inc. Report. Such investors are advised to contact Robert Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (NASDAQ: CABA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. (“Regen” or the “Company”) (OTCMKTS: RGBP). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (RVNC) – Get Revance Therapeutics, Inc. Report and certain of Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of IronNet, Inc. (“IronNet” or the “Company”) (IRNT) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of TPI Composites, Inc. (“TPI” or the “Company”) (TPIC) – Get TPI Composites, Inc. Report. Such investors are advised to contact Robert Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Owlet, Inc. (“Owlet” or the “Company”) f/k/a Sandbridge Acquisition Corporation (“Sandbridge”) (NYSE: OWLT; OWLT WS; SBG) and certain Read more…